We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Australian biotechnology company Vaxine has collaborated with South Korean biopharma firm Medytox for the development and commercialisation of its Covid-19 vaccine candidate, COVAX-19.